Kyowa Kirin, Inc. drugs
3 results
Nourianz (istradefylline)
(istradefylline)Kyowa Kirin, Inc.
Usage: NOURIANZ is indicated as an adjunctive treatment to levodopa/carbidopa for adults with Parkinson's disease (PD) who experience "off" episodes.
Poteligeo (mogamulizumab-kpkc)
(mogamulizumab-kpkc)Kyowa Kirin, Inc.
Usage: POTELIGEO is indicated for treating adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) following at least one prior systemic therapy.
Sancuso (granisetron)
(granisetron)Kyowa Kirin, Inc.
Usage: Sancuso® is indicated for the prevention of nausea and vomiting in adults undergoing moderately to highly emetogenic chemotherapy lasting up to 5 consecutive days.